source
- Podcast explores emerging rapid‑acting and psychedelic therapies for treatment‑resistant depressionIn a recent episode of BioSpace’s Denatured podcast, host Jennifer C. Smith‑Parker talks with Hans Eriksson, chief medical officer of FundaMental Pharma, and Steve Levine, chief patient officer at…
- Choosing Between CROs and Biotechs: How Company Size Shapes the FitWhile biotechs and contract research organizations each have strengths, the article notes that the right choice depends on a company’s specific situation. Ali Pashazadeh, founder and CEO of Treehi…